Cargando…

miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease

Parkinson’s Disease is the second most common neurodegenerative disorder, affecting 1–2% of the elderly population. Its diagnosis is still based on the identification of motor symptoms when a considerable number of dopaminergic neurons are already lost. The development of translatable biomarkers for...

Descripción completa

Detalles Bibliográficos
Autores principales:	dos Santos, Marcia Cristina T., Barreto-Sanz, Miguel Arturo, Correia, Bruna Renata S., Bell, Rosie, Widnall, Catherine, Perez, Luis Tosar, Berteau, Caroline, Schulte, Claudia, Scheller, Dieter, Berg, Daniela, Maetzler, Walter, Galante, Pedro A.F., Nogueira da Costa, Andre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915128/ https://www.ncbi.nlm.nih.gov/pubmed/29707120 http://dx.doi.org/10.18632/oncotarget.24736

Ejemplares similares

Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis
por: T. dos Santos, Marcia Cristina, et al.
Publicado: (2018)

Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
por: Stoessel, Daniel, et al.
Publicado: (2018)

Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without Dementia
por: Maetzler, Walter, et al.
Publicado: (2012)

A potential role for intragenic miRNAs on their hosts' interactome
por: Hinske, Ludwig Christian G, et al.
Publicado: (2010)

GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
por: Maetzler, Walter, et al.
Publicado: (2016)

Cerebrospinal Fluid and Plasma Small Extracellular Vesicles and miRNAs as Biomarkers for Prion Diseases
por: López-Pérez, Óscar, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy: New Data and Quantitative Meta-Analysis
por: Margraf, Nils G., et al.
Publicado: (2022)

Mining of public sequencing databases supports a non-dietary origin for putative foreign miRNAs: underestimated effects of contamination in NGS
por: Tosar, Juan Pablo, et al.
Publicado: (2014)

Parkinson’s Inside Out
por: Stamford, Jon, et al.
Publicado: (2016)

Dual-Task Performance in GBA Parkinson's Disease
por: Srulijes, Karin, et al.
Publicado: (2017)

Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease
por: Gschmack, Eva, et al.
Publicado: (2022)

Comparable Autoantibody Serum Levels against Amyloid- and Inflammation-Associated Proteins in Parkinson’s Disease Patients and Controls
por: Maetzler, Walter, et al.
Publicado: (2014)

Elevation of brain-enriched miRNAs in cerebrospinal fluid of patients with acute ischemic stroke
por: Sørensen, Sofie Sølvsten, et al.
Publicado: (2017)

A Panel of Exosome-Derived miRNAs of Cerebrospinal Fluid for the Diagnosis of Moyamoya Disease
por: Wang, Gang, et al.
Publicado: (2020)

Digitomotography in Parkinson’s Disease: A Cross-Sectional and Longitudinal Study
por: Maetzler, Walter, et al.
Publicado: (2015)

Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology
por: Burgos, Kasandra, et al.
Publicado: (2014)

Use of Cerebrospinal Fluid Biomarkers in Diagnosis and Monitoring of Rheumatoid Meningitis
por: Nissen, Mette Scheller, et al.
Publicado: (2019)

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach
por: van Dijk, Karin D., et al.
Publicado: (2010)

Correction: Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology
Publicado: (2014)

Post-Cueing Deficits with Maintained Cueing Benefits in Patients with Parkinson’s Disease Dementia
por: Gräber, Susanne, et al.
Publicado: (2014)

Novel image–novel location object recognition task sensitive to age-related cognitive decline in nondemented elderly
por: Haley, Gwendolen E., et al.
Publicado: (2011)

MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1
por: Cirilo, Priscila Daniele Ramos, et al.
Publicado: (2017)

Magnetic resonance imaging of cerebrospinal fluid outflow after low-rate lateral ventricle infusion in mice
por: Decker, Yann, et al.
Publicado: (2022)

Letter to editor regarding “piR-36249 and DHX36 together inhibit testicular cancer cells progression by upregulating OAS2”
por: Tosar, Juan Pablo
Publicado: (2023)

Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
por: Willkommen, Desiree, et al.
Publicado: (2018)

Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia
por: Kessler, Christoph, et al.
Publicado: (2021)

Knee Pain from Osteoarthritis: Pathogenesis, Risk Factors, and Recent Evidence on Physical Therapy Interventions
por: Berteau, Jean-Philippe
Publicado: (2022)

Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study
por: Hobert, Markus A., et al.
Publicado: (2019)

Comparison of Methods for miRNA Extraction from Plasma and Quantitative Recovery of RNA from Cerebrospinal Fluid
por: McAlexander, Melissa A., et al.
Publicado: (2013)

Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease: A Longitudinal Cohort Study
por: Becker, Sara, et al.
Publicado: (2022)

Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays
por: Heinzel, Sebastian, et al.
Publicado: (2014)

Effect of Fear of Falling on Turning Performance in Parkinson’s Disease in the Lab and at Home
por: Haertner, Linda, et al.
Publicado: (2018)

Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update
por: Lo Sasso, Bruna, et al.
Publicado: (2019)

Circulating Inflammatory miRNAs Associated with Parkinson’s Disease Pathophysiology
por: Oliveira, Sara R., et al.
Publicado: (2020)

Moderate Frequency Resistance and Balance Training Do Not Improve Freezing of Gait in Parkinson's Disease: A Pilot Study
por: Schlenstedt, Christian, et al.
Publicado: (2018)

Radical SAM Enzymes and Ribosomally‐Synthesized and Post‐translationally Modified Peptides: A Growing Importance in the Microbiomes
por: Benjdia, Alhosna, et al.
Publicado: (2021)

Distinct Relationship Between Cognitive Flexibility and White Matter Integrity in Individuals at Risk of Parkinson’s Disease
por: Alzaid, Haidar, et al.
Publicado: (2020)

Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
por: Barbariga, Marco, et al.
Publicado: (2015)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
por: Hall, Sara, et al.
Publicado: (2016)

Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
por: Zimmermann, Milan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gvkoicb2gmntgcmp2nrikbsfob